Q3 2024 · 13F-HR
Euclidean Capital LLCholdings as filed
Filed 2024-11-14 · accession 0001012975-24-000483
$906.8M
Reported value
12
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $690.1M | 76.1% | 1,202,804 | Common | SOLE |
| 46429B598 | INDA | ISHARES TR | $141.9M | 15.7% | 2,425,144 | Common | SOLE |
| 922042775 | VEU | VANGUARD INTL EQUITY INDEX F | $32.0M | 3.53% | 507,600 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $14.7M | 1.62% | 1,573,761 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $10.1M | 1.12% | 989,410 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $6.1M | 0.67% | 1,307,858 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $3.9M | 0.43% | 2,627,643 | Common | SOLE |
| 90138Q108 | — | 23ANDME HOLDING CO | $3.6M | 0.40% | 10,243,122 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $2.0M | 0.22% | 1,015,705 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.3M | 0.15% | 657,899 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.1M | 0.12% | 87,696 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $1,760 | 0.00% | 170,833 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.